Ebalzotan (developmental code name NAE-086) is a selective 5-HT1A receptor agonist. It was under development as an antidepressant and anxiolytic agent but produced…
Ebalzotan (developmental code name NAE-086) is a selective 5-HT1A receptor agonist. It was under development as an antidepressant and anxiolytic agent but produced undesirable side effects in phase I clinical trials and was subsequently discontinued.
See also 3-Aminochroman 4-HO-PiPT Robalzotan
References
Gebaseerd op: Wikipedia — Ebalzotan · auteursgeschiedenis.
Tekst: CC BY-SA 4.0.
Wikisyntaxis en sjablonen zijn verwijderd; langere teksten zijn ingekort.